Joseph Saddik | Pharmacology, Toxicology and Pharmaceutical Science | Best Innovation Award

Published on by Academic Excellence

Best Innovation Award

Joseph Saddik
Pfizer,United States

Joseph Saddik
Affiliation Pfizer
Country United States
Scopus ID 57223125865
Documents 2
Citations 25
h-index 2
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Excellence Awards
ORCID 0000-0003-1490-9517

Joseph Saddik is identified with research in pharmaceutical science, particularly powder rheology, tablet compaction, compactability, and manufacturing-related performance of acetaminophen tablets. His listed publications address formulation and processing variables associated with tablet manufacture and the prediction or mitigation of sticking during compression. [1][2]

Abstract

The research record associated with Joseph Saddik centers on pharmaceutical powder processing and tablet manufacturing. The documented work examines powder rheology, tablet compactability, and sticking behavior, with particular attention to formulation factors, glidant selection, punch-metal effects, and multivariate analytical approaches. These topics are relevant to pharmaceutical manufacturing because powder flow and compaction characteristics can influence tablet quality and process performance. [2][3]

Keywords

Pharmaceutical science; powder rheology; tablet compression; acetaminophen; compactability; sticking; glidants; punch metals; multivariate analysis.

Introduction

Tablet manufacture involves interconnected material and process variables. Acetaminophen is frequently used as a model active pharmaceutical ingredient for studying compression behavior because formulation and processing conditions can affect compaction and manufacturing outcomes. Research examining these relationships can support improved understanding of tablet formation and compression-related defects. [2]

Research Profile

The supplied researcher record lists Pfizer as the institutional affiliation and identifies Pharmacology, Toxicology and Pharmaceutical Science as the subject area. The supplied bibliographic information records two documents, 25 citations, and an h-index of 2, alongside Scopus author identifier 57223125865. These metrics are bibliographic indicators and should be interpreted in relation to database coverage and publication history. [1]

Research Contributions

The documented studies contribute to the characterization of pharmaceutical powders and compressed tablets. One study evaluates powder rheology as a potential predictor of tablet sticking, while another investigates manufacturing and formulation factors affecting acetaminophen compactability. The 2026 study further develops this research direction by examining glidant type and punch-metal selection in high-drug-load acetaminophen tablets. [2][3][4]

Publications

  • Predicting and Mitigating Sticking in High-Drug-Load Acetaminophen Tablets Using a Powder Rheology-Compression Approach: Evaluation of Glidant Type and Punch Metal Selection. Powders, 2026. [4]
  • Investigating the Impact of Manufacturing and Formulation Factors on the Compactability of Acetaminophen Tablets Using Heckel and Multivariate Analysis. International Journal of Pharmaceutical Sciences and Research, 2021. [2]
  • Evaluation of powder rheology as a potential tool to predict tablet sticking. Powder Technology, 2021. [3]

Research Impact

The reported citation count indicates that the research has received citations within the indexed scholarly literature. Its thematic focus also connects fundamental powder characterization with practical tablet-manufacturing concerns, including sticking and compactability. Such work may be relevant to formulation development and process understanding, although citation metrics alone do not establish practical or clinical impact. [1]

Award Suitability

For consideration in the International Academic Excellence Awards, the documented publication record provides identifiable evidence of research activity in pharmaceutical manufacturing and powder science. The studies present a coherent research theme spanning rheological characterization, compaction analysis, and mitigation of tablet sticking. Award decisions, however, remain subject to the criteria, documentation, and assessment procedures established by the awarding organization. [5]

Conclusion

Joseph Saddik’s documented research is focused on technically specific problems in pharmaceutical tablet manufacture, particularly powder rheology, compactability, and sticking. The available publications demonstrate continuity across these subjects and provide a scholarly basis for describing his research profile within pharmaceutical science. [2][3][4]

References

  1. Elsevier. (n.d.). Scopus author details: Joseph Saddik, Author ID 57223125865. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57223125865
  2. International Journal of Pharmaceutical Sciences and Research. (2021). Investigating the Impact of Manufacturing and Formulation Factors on the Compactability of Acetaminophen Tablets Using Heckel and Multivariate Analysis. DOI: 10.13040/ijpsr.0975-8232.12(2).1240-50
  3. Powder Technology. (2021). Evaluation of powder rheology as a potential tool to predict tablet sticking. DOI: 10.1016/j.powtec.2021.03.062
  4. MDPI. (2026). Predicting and Mitigating Sticking in High-Drug-Load Acetaminophen Tablets Using a Powder Rheology-Compression Approach: Evaluation of Glidant Type and Punch Metal Selection. Powders, 5(3), 31.
    https://doi.org/10.3390/powders5030031
  5. International Academic Excellence Awards. (n.d.). Award program information.
    https://academicexcellenceawards.com/
  6. ORCID. (n.d.). Joseph Saddik, ORCID record 0000-0003-1490-9517.
    https://orcid.org/0000-0003-1490-9517

Prof. Dr. Deepak Khobragade | Pharmacology | Academic Excellence Award

Published on by Academic Excellence

Prof. Dr. Deepak Khobragade | Pharmacology | Academic Excellence Award

Datta Meghe Institute of Higher Education nd Research(DU) | India

Dr. Deepak S. Khobragade is a distinguished academician, administrator, and pharmaceutical professional with over two decades of experience spanning higher education and the pharmaceutical industry. He is currently serving as Professor and Dean (Academics) at Datta Meghe College of Pharmacy, a constituent college of Datta Meghe Institute of Higher Education and Research (DMIHER), Wardha, Maharashtra, where he plays a pivotal role in academic leadership, curriculum development, and institutional growth. Dr. Khobragade has extensive graduate and postgraduate teaching experience, coupled with strong expertise in pharmaceutics, pharmaceutical formulations, and regulatory affairs. His academic journey includes a Ph.D. in Pharmaceutics from R.T.M. Nagpur University, with a research focus on sustained-release drug delivery systems. He also holds an M.Pharm. and B.Pharm., along with additional qualifications in Bioethics and Psychology, reflecting his multidisciplinary approach to education and human development. Before transitioning fully into academia, Dr. Khobragade gained valuable industry exposure with reputed organizations such as Zydus Cadila and Micro Labs Ltd., where he worked in U.S. and European regulatory affairs, strengthening his practical and compliance-oriented perspective. His academic career includes leadership roles as Professor, Associate Professor, Head of Department, Principal, and Dean, demonstrating his strong administrative and strategic capabilities.

Citation Metrics (Scopus)

100
50
25
10
0

Citations
73

Documents
41

h-index
4

Citations

Documents

h-index


View Scopus Profile
  View Google Scholar Profile

Featured Publications

Molecular Docking in Drug Discovery
– Journal of Pharmaceutical Research International, 2021
Health Care Waste: Avoiding Hazards to Living and Non-Living Environment by Efficient Management
– Fortune Journal of Health Sciences, 2019
Development and Evaluation of a Hot-Melt Coating Technique for Enteric Coating
– Brazilian Journal of Pharmaceutical Sciences, 2012
Evaluation of Hot Melt Coating as a Taste Masking Tool
– Research Journal of Pharmaceutical Sciences, 2011
Multi-Model Confirmatory Evaluation of Anti-inflammatory, Analgesic and Antioxidant Activities of Putranjiva roxburghii
– 2013

Syed Suhaib Ahmed | Pharmacology | Young Scientist Award

Published on by Academic Excellence

Prof. Syed Suhaib Ahmed | Pharmacology | Young Scientist Award

Prof. Syed Suhaib Ahmed | Pharmacology | Yenepoya Universtiy | India

Dr. Syed Suhaib Ahmed, M.Pharm., Ph.D., is a dynamic academician and researcher specializing in pharmaceutics and nanomedicine. With a strong foundation in pharmacy, he has advanced his expertise through extensive teaching, research, and scholarly contributions. Currently serving as Assistant Professor at Yenepoya Pharmacy College & Research Centre, Mangalore, he also continues his impactful research journey initiated at JSS College of Pharmacy, Ooty. His Ph.D. project focused on the design and development of surface-conjugated solid lipid nanoparticles co-encapsulating a flavonoid and an anticancer drug for targeted colon cancer therapy. Dr. Ahmed has authored several national and international publications in reputed journals and presented his work at conferences and seminars. His innovative contributions to drug delivery systems, formulation development, and nanotechnology position him as a promising researcher in pharmacology. Recognized with fellowships and grants, Dr. Ahmed embodies academic excellence, research innovation, and a strong commitment to advancing pharmaceutical sciences.

Author Profiles

Orcid | Google Scholar

Education

Dr. Ahmed’s educational foundation reflects his dedication to pharmaceutical sciences. He completed his Bachelor of Pharmacy (B. Pharm.) in 2017 from Nalanda College of Pharmacy, Nalgonda, under JNTUH, securing a solid academic base. To advance his knowledge in drug formulation and delivery, he pursued M.Pharm. (Pharmaceutics) in 2019 at the same institution. His postgraduate research explored “Formulation and in vitro evaluation of doxophylline oral disintegrating tablets,” marking his early entry into formulation design. Driven by a passion for translational research, he enrolled for his Ph.D. (2022–2024) at JSS College of Pharmacy, Ooty, under JSS Academy of Higher Education & Research. His doctoral thesis centered on surface-conjugated solid lipid nanoparticles incorporating irinotecan and daidzein for colon cancer treatment, a study that combined advanced nanotechnology with oncology. This robust academic trajectory highlights his strong theoretical knowledge, practical research expertise, and innovation in pharmaceutics.

Experience

Dr. Ahmed has developed a rich blend of teaching and research experience that strengthens his academic profile. He began his career as a Lecturer at JSS College of Pharmacy, Ooty (Feb 2022 – July 2024), where he taught undergraduate and postgraduate pharmacy students while mentoring research projects. In September 2024, he joined Yenepoya Pharmacy College & Research Centre, Mangalore as an Assistant Professor, further expanding his teaching and mentoring contributions. Alongside academics, Dr. Ahmed has actively engaged in high-impact research, particularly in nanoparticle-based drug delivery systems. His doctoral project on colon-targeted lipid nanoparticles has provided novel insights into cancer therapeutics. Beyond teaching and research, he has attended 29+ conferences, delivered 9 presentations, and participated in 17 workshops, enhancing his professional network and exposure. His expertise in handling advanced instruments like DLS, DSC, XRD, and HPLC, combined with his strong teaching skills, showcases his versatility as both an educator and researcher.

Awards and Honors

Dr. Ahmed’s dedication to pharmaceutical research has been recognized through prestigious awards and fellowships. He was the recipient of the JSSAHER Fellowship, supporting his early-stage Ph.D. research on innovative nanoparticle drug delivery. Additionally, His academic excellence and contributions are further highlighted through multiple opportunities to present his work at national and international platforms. He has actively participated in over 29 conferences, 17 workshops, and 9 oral/poster presentations, gaining recognition for his innovative approaches in pharmaceutics. His scholarly publications in high-impact journals like the International Journal of Biological Macromolecules and Applied Organometallic Chemistry reflect his growing influence in the pharmacology community. These achievements stand as a testament to his perseverance, innovation, and leadership, positioning him as a rising figure in pharmaceutical sciences.

Research Focus

Dr. Ahmed’s research interests lie at the intersection of nanomedicine, targeted drug delivery, and formulation development. His Ph.D. research on solid lipid nanoparticles (SLNs) co-encapsulating irinotecan and daidzein represents a significant step forward in colon cancer therapy, addressing challenges of drug solubility, stability, and targeted delivery. By conjugating nanoparticles with hyaluronic acid and bovine serum albumin, he designed a system capable of actively targeting CD44 and SPARC receptors on colon epithelia, ensuring enhanced therapeutic efficacy. His research includes both in vitro assays on HT-29 colon cancer cells and in vivo studies in Wistar rats, demonstrating translational potential. Beyond oncology, he has contributed to fields like microneedle technology, nanoparticle synthesis, and orphan drug formulation challenges. He is also interested in QbD (Quality by Design) approaches, polymeric drug delivery systems, and risk assessment in pharmaceutical development. His work aims to bridge laboratory innovation with clinical applications, making a tangible impact in pharmacology.

Publications

  1. Oral delivery of SLNs decorated with hyaluronic acid and BSA: Novel colon cancer therapy – IJ of Biological Macromolecules, 2024.

  2. Green synthesis of BSA–silver nanoparticles with anticancer activity – Applied Organometallic Chemistry, 2024.

  3. Exploring multistage nanocarriers for colon cancer treatment – Journal of Research in Pharmacy, 2023.

  4. Challenges in developing generic orphan drugs: US & EU survey – Value in Health Regional Issues, 2023.

  5. Risk assessment in COVID-19 vaccine formulation and transfer – Vitae, 2022.

  6. Folic acid–tailored daidzein SLNs for cytotoxicity against colon cancer – IJ of Applied Pharmaceutics, 2024.

  7. Advancements in microneedle drug delivery systems – IJ of Applied Pharmaceutics, 2024.

  8. Molecular docking studies of benzylidene amino phenyl acetamides – IJ of Applied Pharmaceutics, 2024.

  9. Formulation & evaluation of doxophylline ODTs – Research Journal of Pharmacy and Technology, 2020.

  10. Pharmaceutical product life cycle challenges for generic approvals – Indian J of Pharmaceutical Education & Research, 2022.

Conclusion

Dr. Syed Suhaib Ahmed represents the new generation of pharmacology researchers, combining academic rigor with cutting-edge nanomedicine innovations. His scholarly contributions, teaching excellence, and impactful research on targeted cancer therapies demonstrate his potential to redefine future directions in pharmaceutical sciences. With strong recognition through fellowships, grants, and publications in reputed journals, he is poised to make lasting contributions to pharmacology and translational drug development.